A case of apparent mineralocorticoid excess due to 11 HSD2 deficiency;Un cas d'exces apparent de mineralocorticoides par deficit en 11 β hydroxysteroide-deshydrogenase de type 2

Archives des Maladies du Coeur et des Vaisseaux

Volumn 90, Issue 8, 1997, Pages 1111-1115

  Morineau, G ^a   Pascoe, L ^b   Marc, J M ^c   Caillette, A ^d   Krozowski, Z ^e   Corvol, P ^b   Fiet, J ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b Paris Sciences et Lettres   (France)

^c HÔPITAL DU BOCAGE   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; HYDROCORTISONE; MINERALOCORTICOID; RENIN; CORTISONE; HYDROXYSTEROID DEHYDROGENASE;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERTENSION; KIDNEY TUBULE FUNCTION; MAJOR CLINICAL STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STEROID METABOLISM; BLOOD; CASE REPORT; CHEMISTRY; CHRONIC KIDNEY FAILURE; FEMALE; GENETICS; METABOLISM; MUTATION; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SYNDROME; URINE;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ALDOSTERONE; CHILD, PRESCHOOL; CORTISONE; FEMALE; HUMANS; HYDROXYSTEROID DEHYDROGENASES; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MINERALOCORTICOIDS; MUTATION; RENIN; SYNDROME;

EID: 0031196456     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Sann L, Revol A, Zachmann M, Legrand JC, Bethenod M. Unusual low plasma renin hypertension in a child. J Clin Endocrinol Metab 1975; 43: 265-71.
2. Ulick S, Levine LS, Gunczler P et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979; 49: 757-64.
3. Mune T, Rogerson FM, Nikkilä H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isoenzyme of 11β hydroxysteroid-dehydrogenase. Nature Genet 1995; 10: 394-9.
4. Wilson RC, Krazowski ZS, Li K et al. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995; 80: 2263-6.
5. Wilson RC, Harbison MD, Krozowski ZS et al. Several homozygous mutations in the gene for 11β hydroxysteroiddehydrogenase type 2 in patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995; 80: 3145-50.
6. Obeyesekere VR, Ferrari P, Andrews RK et al. The R337C mutation generates a high Km 11β hydroxysteroid-dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995; 80: 3381-3.
7. Stewart PM, Krozowski ZS, Gupta A et al. Hypertension in the syndrome of apparent mineralocorticoid excess due to the mutation of the 11β hydroxysteroid-dehydrogenase type 2 gene. Lancet 1996; 347: 88-91.
8. Gourmelen M, Saint-Jacques I, Morineau G, Soliman H, Julien R, Fiet J. 11β hydroxysteroid dehydrogenase deficit: a rare cause of arterial hypertension; diagnosis and therapeutic approach in two young brothers. Eur J Endocrin 1996; 135: 238-44.
9. Morineau G, Boudi A, Barka A et al. Intérêdes dosages de cortisone et cortisol dans le syndrome d'excè apparent en minéalocorticoïdes et chez des patients hémodialysés chroniques (résumé). Ann Endocrinol (Paris) 1996; 57: 325.
10. Ulick S, Tedde R, Wang JZ. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 1992; 74: 593-9.